Neglecting infectious diseases is a market failure
Major companies are reducing research on new medicines for illnesses that affect billions of people
Related reading
Healthcare policy is afflicted by short-sightedness
With the NHS in triage mode, business and society need to shift to prevention of ill health
A test for global public health
The decline in funding for vaccinations poses a worldwide threat
War is pushing us to a drug resistance tipping point
Failure to prevent the rise and spread of infections in conflict zones imperils health security everywhere
America’s unfortunate backward step on vaccines
2025 has been a good year for immunisation science, but not in the US
Healthcare is driving America’s economy
This is a huge industry — and that’s not necessarily a good thing
Imbalances are back on the global agenda
Policymakers must overcome the mercantilist fallacy that the way to get rich is by running surpluses forever